A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2

被引:1
|
作者
Abeshi, Andi [1 ]
Ferri, Gian Gaetano [1 ]
机构
[1] Univ Bologna, Dept Med & Surg Sci DIMEC, Otolaryngol & Audiol Unit, IRCCS Azienda Ospedal, Bologna, Italy
来源
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY | 2023年 / 19卷 / 03期
关键词
Vestibular schwannoma; magnetic resonance imaging; neurofibromatosis; 2;
D O I
10.5152/iao.2023.22922
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Bilateral vestibular schwannomas are commonly diagnosed in patients affected by neurofibromatosis type 2, a genetic disease caused by a heterozygous mutation in the gene region encoding neurofibromin-2. Sporadic bilateral vestibular schwannomas are very rare entities affecting almost exclusively elderly people. We present the case of a senior woman who was followed up with the "wait-and-scan" strategy for a unilateral vestibular schwannoma that later developed as a contralateral tumor, compatible with vestibular schwannoma, raising questions about its nature and risk of having been transmitted in offspring. Genetic testing excluded mutations of the neurofibromatosis type 2 gene. The presence of bilateral vestibular schwannomas is often considered pathognomonic of neurofibromatosis type 2, but the estimated probability of sporadic bilateral tumors in the absence of other neurofibromatosis type 2 features is 50% over 70 years of age. Therefore, the NF2 gene assessment is in any case recommended in these patients not only for an evaluation of the risk of being transmitted. The treatment strategy should be carefully personalized for each patient, considering the size of the tumors, symptoms, and hearing function together with the patient's age.
引用
收藏
页码:263 / 265
页数:3
相关论文
共 50 条
  • [1] Bilateral Spontaneous Regression of Vestibular Schwannoma in Neurofibromatosis Type 2
    Sebok, Martina
    van Niftrik, Christiaan Hendrik Bas
    Bozinov, Oliver
    WORLD NEUROSURGERY, 2018, 113 : 195 - 197
  • [2] Cochlear implantation in patients with neurofibromatosis Type 2 and bilateral vestibular schwannoma
    Lustig, Lawrence R.
    Yeagle, Jennifer
    Driscoll, Colin L. W.
    Blevins, Nikolas
    Francis, Howard
    Niparko, John K.
    OTOLOGY & NEUROTOLOGY, 2006, 27 (04) : 512 - 518
  • [3] Treatment of progressive neurofibromatosis type 2-related vestibular schwannoma with erlotinib
    Plotkin, S. R.
    Halpin, C. F.
    McKenna, M. J.
    Batchelor, T. T.
    Loeffler, J. S.
    Barker, F. G., II
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] NEUROFIBROMATOSIS TYPE-2 WITHOUT VESTIBULAR SCHWANNOMA
    MAUTNER, VF
    LINDENAU, M
    KOPPEN, J
    HAZIM, W
    KLUWE, L
    ZENTRALBLATT FUR NEUROCHIRURGIE, 1995, 56 (02): : 83 - 87
  • [5] New developments in neurofibromatosis type 2 and vestibular schwannoma
    Ren, Yin
    Chari, Divya A.
    Vasilijic, Sasa
    Welling, D. Bradley
    Stankovic, Konstantina M.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [6] Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2
    Wagner, J.
    Welzel, T.
    Habermehl, D.
    Debus, J.
    Combs, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 82 - 82
  • [7] Management Strategy of Vestibular Schwannoma in Neurofibromatosis Type 2
    Odat, Haitham Ahmad
    Piccirillo, Enrico
    Sequino, Giuliano
    Taibah, Abdelkader
    Sanna, Mario
    OTOLOGY & NEUROTOLOGY, 2011, 32 (07) : 1163 - 1170
  • [8] Bilateral Vestibular Schwannomas in Neurofibromatosis Type 2
    Meola, Antonio
    Chang, Steven D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1463 - 1463
  • [9] Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2
    Ito, Eiji
    Saito, Kiyoshi
    Yatsuya, Hiroshi
    Nagatani, Tetsuya
    Otsuka, Goro
    NEUROSURGICAL REVIEW, 2009, 32 (04) : 425 - 432
  • [10] Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2
    Baser, ME
    Makariou, EV
    Parry, DM
    JOURNAL OF NEUROSURGERY, 2002, 96 (02) : 217 - 222